Business Development, Risk and Compliance. A Leading Asset Manager in Healthcare. A Leading Asset Manager in Healthcare. HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. Dr Andreas Wicki, CEO.

Invests in a broad range of healthcare companies across multiple sectors and stages of development. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs more. Thu, Jan 25th, 2018. Tue, Jan 9th, 2018.

Genetic reports for consumers to better appreciate their ancestry. Small-molecule therapeutics that modulate miRNAs for treatment. Previously committed to developing novel drugs. Clinical stage pharmaceutical company for pulmonary disorders. Previously developed new treatments for metabolic conditions. Cancer and inflammatory disease therapeutic company. Orally-delivered protein therapeutics to treat metabolic diseases. Developing drugs for autoimmune diseases.

Yale Device and Diagnostic Pipeline. Patent Policy Acknowledgement and Agreement. Management of Equity in New Ventures. Consulting and the Patent Policy. Support for Yale Student Innovators.